Terms: = Liver cancer AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257 AND Treatment
699 results:
1. Epithelial-Mesenchymal Transformation Promotes the Progression of Hepatocellular Carcinoma through NF-κB/MMP9 Axis.
Li J; Cai Q; Wang Z; Wang L; Yang G; Zhang Z; Ge N; Hu S; Bai T
Discov Med; 2024 Apr; 36(183):666-677. PubMed ID: 38665016
[TBL] [Abstract] [Full Text] [Related]
2. Re-exploration of immunotherapy targeting emt of hepatocellular carcinoma: Starting from the NF-κB pathway.
Wang S; He Y; Wang J; Luo E
Biomed Pharmacother; 2024 May; 174():116566. PubMed ID: 38631143
[TBL] [Abstract] [Full Text] [Related]
3. Jolkinolide B inhibits the progression of hepatocellular carcinoma by regulating Musashi-2 protein.
Wu T; Yang H; Li J; Fang H; Shi X; Li J; Feng L
PLoS One; 2024; 19(4):e0299920. PubMed ID: 38630658
[TBL] [Abstract] [Full Text] [Related]
4. The ADAM17 inhibitor ZLDI-8 sensitized hepatocellular carcinoma cells to sorafenib through Notch1-integrin β-talk.
Xu C; Gao X; Ren T; Geng H; Yang K; Huang Y; Zhang W; Hou S; Song A; Zhang Y; Zhao Q
Pharmacol Res; 2024 May; 203():107142. PubMed ID: 38522759
[TBL] [Abstract] [Full Text] [Related]
5. The crosstalk between cholangiocytes and hepatic stellate cells promotes the progression of epithelial-mesenchymal transition and periductal fibrosis during Clonorchis sinensis infection.
Yi J; Jeong JH; Won J; Chung S; Pak JH
Parasit Vectors; 2024 Mar; 17(1):151. PubMed ID: 38519993
[TBL] [Abstract] [Full Text] [Related]
6. Epigenetic regulation of hepatocellular carcinoma progression: MicroRNAs as therapeutic, diagnostic and prognostic factors.
Hashemi M; Daneii P; Asadalizadeh M; Tabari K; Matinahmadi A; Bidoki SS; Motlagh YSM; Jafari AM; Ghorbani A; Dehghanpour A; Nabavi N; Tan SC; Rashidi M; Taheriazam A; Entezari M; Goharrizi MASB
Int J Biochem Cell Biol; 2024 May; 170():106566. PubMed ID: 38513802
[TBL] [Abstract] [Full Text] [Related]
7. Exosomal IGFBP2 derived from highly metastatic promotes hepatocellular carcinoma metastasis by inducing epithelial mesenchymal transition.
Zheng Y; Li W; Huang Y; Cheng H
Gene; 2024 Jun; 913():148374. PubMed ID: 38490505
[TBL] [Abstract] [Full Text] [Related]
8. Oridonin inhibited epithelial-mesenchymal transition of laryngeal carcinoma by positively regulating LKB1/AMPK signaling.
Kou B; Shi Y; Zhou Z; Yun Y; Wu Q; Zhou J; Liu W
Int J Med Sci; 2024; 21(4):623-632. PubMed ID: 38464825
[TBL] [Abstract] [Full Text] [Related]
9. Paris polyphylla ethanol extract and polyphyllin I ameliorate adenomyosis by inhibiting epithelial-mesenchymal transition.
Shi YX; Xu L; Wang X; Zhang KK; Zhang CY; Liu HY; Ding PP; Shi W; Liu ZY
Phytomedicine; 2024 May; 127():155461. PubMed ID: 38452697
[TBL] [Abstract] [Full Text] [Related]
10. Long-term di-(2-ethylhexyl) phthalate exposure reduces sorafenib treatment efficacy by enhancing mesenchymal transition in hepatocellular carcinoma.
Shih MS; Suk FM; Chiu WC; Lee CY; Hsu FY; Liao YJ
Ecotoxicol Environ Saf; 2024 Mar; 273():116161. PubMed ID: 38430581
[TBL] [Abstract] [Full Text] [Related]
11. USP14 exhibits high expression levels in hepatocellular carcinoma and plays a crucial role in promoting the growth of liver cancer cells through the HK2/AKT/P62 axis.
Zhang N; Zhang H; Yang X; Xue Q; Wang Q; Chang R; Zhu L; Chen Z; Liu X
BMC Cancer; 2024 Feb; 24(1):237. PubMed ID: 38383348
[TBL] [Abstract] [Full Text] [Related]
12. Targeting LEF1-mediated epithelial-mesenchymal transition reverses lenvatinib resistance in hepatocellular carcinoma.
Li X; Su H; Tang W; Shu S; Zhao L; Sun J; Fan H
Invest New Drugs; 2024 Apr; 42(2):185-195. PubMed ID: 38372948
[TBL] [Abstract] [Full Text] [Related]
13. Molecular mechanisms of pancreatic cancer liver metastasis: the role of PAK2.
Yang H; Li Z; Zhu S; Wang W; Zhang J; Zhao D; Zhang M; Zhu W; Xu W; Xu C
Front Immunol; 2024; 15():1347683. PubMed ID: 38343537
[TBL] [Abstract] [Full Text] [Related]
14. Ubiquitination-specific protease 7 enhances stemness of hepatocellular carcinoma by stabilizing basic transcription factor 3.
Hu M; Dai C; Sun X; Chen Y; Xu N; Lin Z; Xu S; Cheng C; Tan Z; Bian S; Zheng W
Funct Integr Genomics; 2024 Feb; 24(1):28. PubMed ID: 38340226
[TBL] [Abstract] [Full Text] [Related]
15. Th17 Cells Secrete TWEAK to Trigger Epithelial-Mesenchymal Transition and Promote Colorectal cancer liver Metastasis.
Liu X; Wang X; Yang Q; Luo L; Liu Z; Ren X; Lei K; Li S; Xie Z; Zheng G; Zhang Y; Hao Y; Zhou Q; Hou Y; Fang F; Song W; Cui J; Ma J; Xie W; Shen S; Tang C; Peng S; Yu J; Kuang M; Song X; Wang F; Xu L
Cancer Res; 2024 Apr; 84(8):1352-1371. PubMed ID: 38335276
[TBL] [Abstract] [Full Text] [Related]
16. [Plectin Promotes the Migration of Hepatocellular Carcinoma Cells Through Inducing F-actin Polymerization].
Xu R; Yang L; Song G
Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Jan; 55(1):60-66. PubMed ID: 38322534
[TBL] [Abstract] [Full Text] [Related]
17. Downregulation of Roundabout guidance receptor 2 suppresses hepatocellular carcinoma progression by interacting with Y-box binding protein 1.
Liu T; Zhai C; Tian B; Li C; Han S; Wang S; Xuan M; Liu D; Zhao Y; Zhao H; Yu W; Wang J
Sci Rep; 2024 Jan; 14(1):2588. PubMed ID: 38297025
[TBL] [Abstract] [Full Text] [Related]
18. Circular RNA DNAH14 molecular mechanism in an experimental model of hepatocellular carcinoma treated with Cobalt chloride to mimic the hypoxia-like response of transcatheter arterial chemoembolization.
Liao Q; Xia W; Chen J; Wang K; Xiao E
Sci Rep; 2024 Jan; 14(1):1992. PubMed ID: 38263208
[TBL] [Abstract] [Full Text] [Related]
19. PTBP1 promotes the progression of hepatocellular carcinoma by enhancing the oncogenic splicing switch of FGFR2.
Yu-Ying C; Qian Z; Meng-Hui G; Lan F; Peng-Bo C; Gang-Qiao Z
Yi Chuan; 2024 Jan; 46(1):46-62. PubMed ID: 38230456
[TBL] [Abstract] [Full Text] [Related]
20. Curcumol Inhibits the Progression of Hepatocellular Carcinoma by Regulating the Expression of hsa_circ_0028861.
Wu Y; Tang H; Liao Q; Tu Y; Fang S; He J; Cui S
Cancer Biother Radiopharm; 2024 Apr; 39(3):203-210. PubMed ID: 38181186
[No Abstract] [Full Text] [Related]
[Next]
